Literature DB >> 30787145

Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal Pathogen.

James R Johnson1, Brian D Johnston2, Stephen B Porter3, Connie Clabots3, Tricia L Bender3, Paul Thuras3,4, Darren J Trott5, Rowland Cobbold6, Joanne Mollinger5, Patricia Ferrieri7,8, Sarah Drawz8, Ritu Banerjee9.   

Abstract

Escherichia coli sequence type 1193 (ST1193) is an emerging multidrug-resistant pathogen. We performed longitudinal and cross-sectional surveillance for ST1193 among clinical and fecal E. coli isolates from Minneapolis Veterans Affairs Medical Center (VAMC) patients and their household members, other Minnesota centers, and national VAMCs and compared these ST1193 isolates with archival human and canine ST1193 isolates from Australia (2008). We also developed and extensively validated a novel multiplex PCR assay for ST1193 and its characteristic fimH64 (type 1 fimbrial adhesin) allele. We found that ST1193-H64 (where "H64" refers to a phylogenetic subdivision within ST1193 that is characterized by the fimH64 allele), which was uniformly fluoroquinolone resistant, appeared to emerge in the United States in a geographically staggered fashion beginning around 2011. Its prevalence among clinical and fecal E. coli isolates at the Minneapolis VAMC rose rapidly beginning in 2013, peaked in early 2017, and then plateaued or declined. In comparison with other ST14 complex (STc14) isolates, ST1193-H64 isolates were more extensively multidrug resistant, whereas their virulence genotypes were less extensive but included (uniquely) K1 capsule and fimH64 Pulsed-field gel electrophoresis separated ST1193-H64 isolates from other STc14 isolates and showed genetic commonality between archival Australian versus recent U.S. isolates, fecal versus clinical isolates, and human versus canine isolates. Three main ST1193 pulsotypes differed significantly in resistance profiles and capsular types; emergent pulsotype 2123 was associated with trimethoprim-sulfamethoxazole resistance and K1 (versus K5) capsule. These findings clarify ST1193-H64's temporal prevalence trends as a fluoroquinolone-resistant pathogen and commensal; document clonal subsets with distinctive geographic, temporal, resistance, and virulence gene associations; and establish a new laboratory tool for rapid and simple detection of ST1193-H64.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Escherichia colizzm321990; PCR; ST1193; antimicrobial resistance; fluoroquinolone resistance; intestinal colonization; molecular epidemiology; surveillance; veterinary epidemiology; zoonotic infections

Year:  2019        PMID: 30787145      PMCID: PMC6498021          DOI: 10.1128/JCM.01664-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  51 in total

1.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia.

Authors:  Olivier Clermont; James R Johnson; Megan Menard; Erick Denamur
Journal:  Diagn Microbiol Infect Dis       Date:  2006-10-03       Impact factor: 2.803

3.  Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.

Authors:  Gemma Croxall; James Hale; Vivienne Weston; Georgina Manning; Phil Cheetham; Mark Achtman; Alan McNally
Journal:  J Antimicrob Chemother       Date:  2011-08-22       Impact factor: 5.790

4.  P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli.

Authors:  F Nowrouzian; I Adlerberth; A E Wold
Journal:  Epidemiol Infect       Date:  2001-02       Impact factor: 2.451

5.  Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet.

Authors:  Efrain M Ribot; M A Fair; R Gautom; D N Cameron; S B Hunter; B Swaminathan; Timothy J Barrett
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

Review 6.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  The rise and fall of Escherichia coli O15 in a London teaching hospital.

Authors:  P M O'Neill; C A Talboys; A P Roberts; B S Azadian
Journal:  J Med Microbiol       Date:  1990-09       Impact factor: 2.472

Review 8.  Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

Authors:  Thomas A Russo; James R Johnson
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

9.  Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.

Authors:  Sherry P Smith; Amee R Manges; Lee W Riley
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

10.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

View more
  20 in total

1.  Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.

Authors:  Brian D Johnston; Paul Thuras; Stephen B Porter; Melissa Anacker; Brittany VonBank; Paula Snippes Vagnone; Medora Witwer; Mariana Castanheira; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Large Fecal Reservoir of Escherichia coli Sequence Type 131-H30 Subclone Strains That Are Shared Within Households and Resemble Clinical ST131-H30 Isolates.

Authors:  Muhanad Mohamed; Connie Clabots; Stephen B Porter; Tricia Bender; Paul Thuras; James R Johnson
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

Review 3.  Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.

Authors:  Johann D D Pitout; Gisele Peirano; Liang Chen; Rebekah DeVinney; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2022-06-06       Impact factor: 5.938

4.  Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain.

Authors:  Javier Fernández; Azucena Mora; Isidro García-Meniño; Pilar Lumbreras; Luz Lestón; Mónica Álvarez-Álvarez; Vanesa García; Jens Andre Hammerl
Journal:  Microbiol Spectr       Date:  2022-05-23

5.  Novel Multiplex PCR Method and Genome Sequence-Based Analog for High-Resolution Subclonal Assignment and Characterization of Escherichia coli Sequence Type 131 Isolates.

Authors:  Brian D Johnston; David M Gordon; Samantha Burn; Timothy J Johnson; Bonnie P Weber; Elizabeth A Miller; James R Johnson
Journal:  Microbiol Spectr       Date:  2022-05-23

6.  Intestinal Persistence of Colonizing Escherichia coli Strains, Especially ST131-H30, in Relation to Bacterial and Host Factors.

Authors:  James R Johnson; Connie Clabots; Stephen B Porter; Tricia Bender; Brian D Johnston; Paul Thuras
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

7.  Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.

Authors:  Brian D Johnston; Paul Thuras; Stephen B Porter; Melissa Anacker; Brittany VonBank; Paula Snippes Vagnone; Medora Witwer; Mariana Castanheira; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

8.  Unveiling the Virulent Genotype and Unusual Biochemical Behavior of Escherichia coli ST59.

Authors:  Ana Carolina de Mello Santos; Bruna Fuga; Fernanda Esposito; Brenda Cardoso; Fernanda Fernandes Santos; Tiago Barcelos Valiatti; José Francisco Santos-Neto; Ana Cristina Gales; Nilton Lincopan; Rosa Maria Silva; Tânia Aparecida Tardelli Gomes
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

9.  Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and resistance to comparator agents.

Authors:  Brian D Johnston; Paul Thuras; Stephen B Porter; Connie Clabots; James R Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-23       Impact factor: 5.103

10.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.